Skip to main content
OpenTrials

Clinical trial condition

Myotonic Dystrophy Type 1 (DM1)

Explore clinical trials studying Myotonic Dystrophy Type 1 (DM1). Study availability and eligibility vary by location and protocol.

15 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Myotonic Dystrophy Type 1 (DM1) trial results

Recruiting

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

NCT07486934

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DM1, Genetic Diseases, Inborn, +18 more
Locations
  • UCSD - Altman Clinical and Translational Research Institute La Jolla, California, United States
  • Rare Disease Research, LLC Atlanta, Georgia, United States
  • IU Health Neuroscience Center Indianapolis, Indiana, United States
  • Roy Blunt NextGen Precision Health Institute Columbia, Missouri, United States
View all 24 locations
View Trial Details
Recruiting

Personalized Training for People With Rare Neuromuscular Disorders

NCT06708468

Conditions
Charcot Marie Tooth Disease (CMT), Charcot-Marie-Tooth Disease, Congenital Abnormalities, +20 more
Locations
  • Haukeland University Hospital Bergen, Norway
  • Helse Møre and Romsdal HF (Molde Hospital) Molde, Norway
  • Namsos Hospital Namsos, Norway
  • Oslo University Hospital Oslo, Norway
View Trial Details
Recruiting

A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)

NCT06185764

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +15 more
Locations
  • Stanford Neuromuscular Research San Carlos, California, United States
  • University of Florida Clinical Research Center Gainesville, Florida, United States
  • University of Kansas Medical Center Fairway, Kansas, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View all 26 locations
View Trial Details
Recruiting

Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1

NCT05481879

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +10 more
Locations
  • Stanford University Stanford, California, United States
  • University of Florida College of Medicine Gainesville, Florida, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
  • University of Iowa Iowa City, Iowa, United States
View all 20 locations
View Trial Details
Enrolling by Invitation

A Study of Long-term Safety and Efficacy of VX-670 in Participants With Myotonic Dystrophy Type I

NCT06926621

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +15 more
Locations
  • Wesley Research Institute Auchenflower, Australia
  • Neuroscience Clinical Trials Unit, Alfred Brain Melbourne, Australia
  • Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg - Pulmonology Leuven, Belgium
  • Altasciences Montreal Montreal, Canada
View all 13 locations
View Trial Details
Completed

Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients

NCT05027269

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DM1, Dystrophy Myotonic, +15 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
  • University of Colorado Denver, Colorado, United States
  • University of Florida Gainesville, Florida, United States
View Trial Details

Related conditions